Beam Therapeutics BEAM MA — Tax Credits Expiration Starting Year

Similar metrics at other companies

MAZEMA — Tax Credit Carryforward Expiration Start Year

508.5—

MAZEMA — Tax Credit Carryforward Expiration End Year

509.5—

NOVTUS State Credits — Tax Credit Carryforward Expiration Year

511.5+0.3%

MAZEMA — Tax Credit Carryforward Amount

$235K—

AMBAFederal And State — Research Tax Credit Carry Forwards Expiration Period Year Start

5090.0%

PRSUIS — Tax Credit Carryforward Expiration Year

5070.0%

Questions, answered.

What is Beam Therapeutics's MA — tax credits expiration starting year?

Beam Therapeutics (BEAM) reported MA — tax credits expiration starting year of 509.5 in Q4 2025.

How has Beam Therapeutics's MA — tax credits expiration starting year changed year-over-year?

Beam Therapeutics's MA — tax credits expiration starting year decreased by 0.0% year-over-year, from 509.5 to 509.5.

What is the long-term trend for Beam Therapeutics's MA — tax credits expiration starting year?

Over 4 years (2021 to 2025), Beam Therapeutics's MA — tax credits expiration starting year has grown at a 0.1% compound annual growth rate (CAGR), from 2K to 2K.

What does MA — tax credits expiration starting year mean?

Indicates the earliest fiscal year in which the current pool of tax credits for a specific segment begins to expire. Monitoring this date is critical for assessing the urgency of utilizing tax assets before they are forfeited. It provides investors with visibility into the time horizon available for the company to realize the full value of its tax incentives.